The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients
Journal of the European Academy of Dermatology and Venereology · 2025-01 · 39 (1)
DOI: 10.1111/jdv.20111 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 19.05.2024. Verfasst von Cataldo Patruno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Data that support the findings of this study are available from the corresponding author, upon reasonable request.
Autor:innen und Institutionen
- Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Luca Potestio, Maddalena Napolitano
Zitieren
APA
Patruno, C., Potestio, L., Cecere, D., Cosenza, A., Brescia, C., & Napolitano, M. (2025). The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients. Journal of the European Academy of Dermatology and Venereology, 39(1). https://doi.org/10.1111/jdv.20111
Vancouver
Patruno C, Potestio L, Cecere D, Cosenza A, Brescia C, Napolitano M. The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients. Journal of the European Academy of Dermatology and Venereology. 2025;39(1). doi:10.1111/jdv.20111
BibTeX
@article{Patruno2025,
author = {Patruno, Cataldo and Potestio, Luca and Cecere, Daniele and Cosenza, Andrea and Brescia, Claudio and Napolitano, Maddalena},
title = {The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {1},
doi = {10.1111/jdv.20111}
}
EUVIMED